Mark Douglas Smith
Director · Jazz Pharmaceuticals plc
IndividualSelling only1 10b5-1 trade
- 2025
- Sep 2, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark Douglas Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bruce C. Cozadd - $27.78M in JAZZ purchases and sales in the last 12 months
- Robert Iannone - $20.41M in JAZZ purchases and sales in the last 12 months
- Neena M. Patil - $11.50M in JAZZ purchases and sales in the last 12 months
- Patricia Carr - $1.66M in JAZZ purchases and sales in the last 12 months
- Rick E. Winningham - $1.66M in JAZZ purchases and sales in the last 12 months
- Samantha Pearce - $1.63M in JAZZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Douglas Smith?
Mark Douglas Smith is a corporate insider, tracked as Director of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark Douglas Smith submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Mark Douglas Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($470K) across all tracked filings.
